Apg Asset Management N.V. Abbott Laboratories Transaction History

Apg Asset Management N.V.

$61 Billion
Q1 2024

A detailed history of Apg Asset Management N.V. transactions in Abbott Laboratories stock. As of the latest transaction made, Apg Asset Management N.V. holds 1,439,288 shares of ABT stock, worth $149 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

1,439,288

Previous 1,576,765 8.72%

Holding current value

$149 Million

Previous $174 Million 5.74%

% of portfolio

0.27%

Previous 0.31%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$109.52 - $120.96 $15.1 Million - $16.6 Million	-137,477 Reduced 8.72%	1,439,288 $164 Million
Q4 2023 Feb 13, 2024	SELL	$90.19 - $110.4 $1.63 Million - $1.99 Million	-18,068 Reduced 1.13%	1,576,765 $174 Million
Q3 2023 Nov 14, 2023	SELL	$95.53 - $114.62 $14.7 Million - $17.6 Million	-153,540 Reduced 8.78%	1,594,833 $154 Million
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $23.9 Million - $26.7 Million	-237,513 Reduced 11.96%	1,748,373 $191 Million
Q1 2023 May 12, 2023	SELL	$96.86 - $114.01 $16.6 Million - $19.5 Million	-171,449 Reduced 7.95%	1,985,886 $201 Million

Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $139 Million - $163 Million	1,462,926 Added 210.67%	2,157,335 $237 Million
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $9.55 Million - $11.1 Million	-98,669 Reduced 12.44%	694,409 $68.6 Million
Q2 2022 Aug 12, 2022	SELL	$102.07 - $123.37 $4.93 Million - $5.96 Million	-48,301 Reduced 5.74%	793,078 $82.4 Million
Q1 2022 May 12, 2022	SELL	$114.02 - $139.04 $17.8 Million - $21.7 Million	-155,880 Reduced 15.63%	841,379 $89.5 Million
Q4 2021 Feb 11, 2022	BUY	$115.53 - $141.46 $12.1 Million - $14.8 Million	104,355 Added 11.69%	997,259 $123 Million
Q3 2021 Nov 15, 2021	SELL	$116.66 - $129.06 $12.7 Million - $14 Million	-108,800 Reduced 10.86%	892,904 $91 Million
Q2 2021 Aug 13, 2021	SELL	$105.79 - $124.53 $10.6 Million - $12.5 Million	-100,129 Reduced 9.09%	1,001,704 $97.9 Million
Q1 2021 May 14, 2021	SELL	$108.84 - $128.23 $95.2 Million - $112 Million	-875,047 Reduced 44.26%	1,101,833 $112 Million
Q4 2020 Feb 12, 2021	SELL	$105.0 - $114.42 $7.64 Million - $8.32 Million	-72,723 Reduced 3.55%	1,976,880 $177 Million
Q3 2020 Nov 12, 2020	SELL	$91.64 - $111.29 $847,303 - $1.03 Million	-9,246 Reduced 0.45%	2,049,603 $190 Million
Q2 2020 Aug 14, 2020	BUY	$76.57 - $98.0 $3.63 Million - $4.65 Million	47,402 Added 2.36%	2,058,849 $168 Million
Q1 2020 May 15, 2020	BUY	$62.82 - $91.86 $88.9 Million - $130 Million	1,414,364 Added 236.88%	2,011,447 $159 Million
Q1 2020 May 14, 2020	SELL	$62.82 - $91.86 $8.14 Million - $11.9 Million	-129,642 Reduced 17.84%	597,083 $42.5 Million
Q4 2019 Feb 13, 2020	SELL	$78.51 - $87.4 $31.2 Million - $34.7 Million	-397,100 Reduced 35.33%	726,725 $56.2 Million
Q3 2019 Nov 08, 2019	BUY	$81.84 - $88.74 $29 Million - $31.5 Million	354,642 Added 46.11%	1,123,825 $86.3 Million
Q2 2019 Aug 13, 2019	BUY	$72.88 - $85.0 $12.5 Million - $14.6 Million	172,100 Added 28.82%	769,183 $56.8 Million
Q1 2019 May 14, 2019	SELL	$66.22 - $80.06 $5.53 Million - $6.69 Million	-83,500 Reduced 12.27%	597,083 $42.5 Million
Q4 2018 Feb 13, 2019	BUY	$65.56 - $74.27 $5.61 Million - $6.36 Million	85,600 Added 14.39%	680,583 $43.1 Million
Q3 2018 Nov 09, 2018	BUY	$60.81 - $73.36 $158,106 - $190,736	2,600 Added 0.44%	594,983 $37.6 Million
Q2 2018 Aug 13, 2018	SELL	$57.57 - $63.54 $3.85 Million - $4.24 Million	-66,800 Reduced 10.13%	592,383 $30.9 Million
Q1 2018 May 14, 2018	BUY	$56.27 - $63.62 $106,913 - $120,878	1,900 Added 0.29%	659,183 $32.1 Million
Q4 2017 Jan 24, 2018	SELL	$53.68 - $57.47 $19.7 Million - $21.1 Million	-366,660 Reduced 35.81%	657,283 $31.2 Million
Q3 2017 Oct 19, 2017	BUY	$48.06 - $53.64 $49.2 Million - $54.9 Million	1,023,943	1,023,943 $54.6 Million

Others Institutions Holding ABT

# of Institutions

3,129

Shares Held

1.29B

Call Options Held

8.43M

Put Options Held

8.71M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $181B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Apg Asset Management N.V., based on Form 13F filings with the SEC.

News

Stay updated on Apg Asset Management N.V. with notifications on news.

Account

Apg Asset Management N.V. Abbott Laboratories Transaction History